Is there any data to quote possible benefit of endocrine therapy in an elderly woman with low risk breast cancer who is refusing primary surgical treatment?  

Essentially, is there any role for "COMET trial" type therapy for a low risk elderly patient? 

 



Answer from: Medical Oncologist at Academic Institution